SPR Therapeutics, Inc. Appoints Josh Boggs, PhD, As Chief Scientific Officer
As the newly appointed Chief Scientific Officer, Dr. Joseph (Josh) Boggs will lead SPR Therapeutics Inc’s team of scientists and biomedical engineers in developing non-opioid treatments and minimally …